🔎 Trials Near Me

Home › Colorectal Cancer › New York › Buffalo

Colorectal Cancer clinical trials in Buffalo, NY

6 studies for Colorectal Cancer are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

RecruitingPhase 1/2
  • Roswell Park Cancer Institute, Buffalo
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT03965234

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

RecruitingHealthy volunteers welcome
  • Jacobs School of Medicine & Biomedical Sciences, State University of New York at Buffalo, Buffalo
Ages 19 to 80 · All sexes · Updated Aug 5, 2026 · NCT05826743

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

RecruitingPhase 1/2
  • Roswell Park Cancer Institute, Buffalo
Ages 18 and older · All sexes · Updated Jun 5, 2026 · NCT06307548

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

RecruitingPhase 1
  • Roswell Cancer Institute, Buffalo
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07094204

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

RecruitingPhase 1
  • Roswell Park Cancer Institute, Buffalo
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT04511039

About Colorectal Cancer

Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.

More about Colorectal Cancer on MedlinePlus

Colorectal Cancer trials in other cities

Other studies in Buffalo

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.